Evidence map›Paper›PMID 28272311›Full record

ArticleMolecules (Basel, Switzerland)2017

Synthesis and Biological Activities of Ethyl 2-(2-pyridylacetate) Derivatives Containing Thiourea, 1,2,4-triazole, Thiadiazole and Oxadiazole Moieties.

Daniel Szulczyk, Piotr Tomaszewski, Michał Jóźwiak, Anna E Kozioł, Tadeusz Lis, David Collu, Filippo Iuliano, Marta Struga

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Daniel SzulczykDepartment of Biochemistry and Pharmacogenomics, Faculty of Pharmacy, Medical University of Warsaw, 02-097 Warsaw, Poland. daniel.szulczyk@wum.edu.pl.
Piotr TomaszewskiDepartment of Biochemistry, Second Faculty of Medicine, Medical University of Warsaw, 02-097 Warsaw, Poland. piotr.tomaszewski@wum.edu.pl.
Michał JóźwiakDepartment of Biochemistry and Pharmacogenomics, Faculty of Pharmacy, Medical University of Warsaw, 02-097 Warsaw, Poland. michal.jozwiak@wum.edu.pl.
Anna E KoziołFaculty of Chemistry, Maria Curie-Sklodowska University, 20-031 Lublin, Poland. anna.koziol@poczta.umcs.lublin.pl.
Tadeusz LisFaculty of Chemistry, University of Wroclaw, 50-383 Wroclaw, Poland. tadeusz.lis@chem.uni.wroc.pl.
David ColluDepartment of Life and Environmental Sciences, Section of Microbiology and Virology, University of Cagliari, 09042 Cittadella Universitaria Monserrato, Italy. david.collu@unica.it.
Filippo IulianoDepartment of Molecular Medicine, Institute of Virology, Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovak. filippo.iuliano@unica.it.
Marta StrugaDepartment of Biochemistry and Pharmacogenomics, Faculty of Pharmacy, Medical University of Warsaw, 02-097 Warsaw, Poland. marta.struga@wum.edu.pl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thirty six novel heterocyclic derivatives of ethyl 2-(2-pyridylacetate) were efficiently synthesized. The new compounds involve the linkage of a 2-pyridyl ring with thiosemicarbazide (compounds

Indexed as

Anti-Infective AgentsBacteriaCell LineCells, CulturedCrystallography, X-RayFungiHIV-1HumansMicrobial Sensitivity TestsModels, MolecularMolecular StructureOxadiazolesStructure-Activity RelationshipThiadiazolesThioureaTriazoles1,2,4-triazoleAnti-Infective AgentsOxadiazolesThiadiazolesThioureaTriazoles1,2,4-triazole1,3,4-oxadiazole1,3,4-thiadiazolebiological activitythioureaX-ray crystal structure analysis

Identifiers

PMID28272311
PMCPMC6155191

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.